InvestorsHub Logo

genisi

05/24/07 9:45 AM

#1599 RE: midastouch017 #1598

Good to have you back, now I can have my traditional
SHLAF SHTUNDE every day :)

Idit

genisi

03/13/08 10:54 AM

#1920 RE: midastouch017 #1598

Results from phase II GoALS trial show (as expected) that Copaxone 40mg was safe and well-tolerated in ALS patients; however, the study's primary and secondary endpoints were not met.

http://biz.yahoo.com/bw/080313/20080313005597.html?.v=1